Also recently it was shown that the combination of FAK inhibitor Y15 with gemcitabine was more effective in suppressing tumor growth in a pancreatic cancer mouse xenograft model than the use of a single drug alone [147]. Here, PTK2 is linked to familial pancreatic carcinoma.